These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 7243391)
21. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia. Nikkilä EA; Ylikahri R; Huttunen JK Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608 [TBL] [Abstract][Full Text] [Related]
22. [Lipoprotein (a) in children with chronic renal failure treated conservatively]. Zwolińska D; Kiliś-Pstrusińska K; Szprynger K Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709 [TBL] [Abstract][Full Text] [Related]
23. Tracking of serum cholesterol and lipoprotein levels from the first year of life. Kallio MJ; Salmenperä L; Siimes MA; Perheentupa J; Miettinen TA Pediatrics; 1993 May; 91(5):949-54. PubMed ID: 8474815 [TBL] [Abstract][Full Text] [Related]
24. Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal. Chan MK; Varghese Z; Persaud JW; Baillod RA; Moorhead JF Clin Nephrol; 1982 Apr; 17(4):183-90. PubMed ID: 7075035 [TBL] [Abstract][Full Text] [Related]
25. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426 [TBL] [Abstract][Full Text] [Related]
26. Effect of anticholesterol therapy on soluble ICAM-1 in chronic stroke patients with hyperlipidemia. Tomiyasu H; Ishikawa K; Yamamoto M; Hata T; Ohta T; Kitagawa Y; Shinohara Y Tokai J Exp Clin Med; 2005 Apr; 30(1):63-9. PubMed ID: 15952300 [TBL] [Abstract][Full Text] [Related]
27. Alcohol intake, cigarette smoking and plasma lipids and lipoproteins in 12--19-year-old children. The Collaborative Lipid Research Clinics Prevalence Study. Glueck CJ; Heiss G; Morrison JA; Khoury P; Moore M Circulation; 1981 Sep; 64(3 Pt 2):III 48-56. PubMed ID: 7020984 [TBL] [Abstract][Full Text] [Related]
34. Serum lipids in chronic renal failure. Wochos DN; Anderson CF; Mitchell JC Mayo Clin Proc; 1976 Oct; 51(10):660-4. PubMed ID: 966817 [TBL] [Abstract][Full Text] [Related]
35. Hyperlipidemia in children on peritoneal dialysis: effect of energy intake on serum triglyceride. Tanaka Y; Hataya H; Araki Y; Ikeda M; Matsuyama T; Honda M Perit Dial Int; 2002; 22(3):426-8. PubMed ID: 12227408 [No Abstract] [Full Text] [Related]
36. Hyperlipidemia in pediatric hemodialysis and renal transplant patients. Associated with coronary artery disease. Pennisi AJ; Heuser ET; Mickey MR; Lipsey A; Malekzadeh MH; Fine RN Am J Dis Child; 1976 Sep; 130(9):957-61. PubMed ID: 786006 [TBL] [Abstract][Full Text] [Related]
37. Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease. Khandelwal P; Murugan V; Hari S; Lakshmy R; Sinha A; Hari P; Bagga A Pediatr Nephrol; 2016 Aug; 31(8):1313-20. PubMed ID: 26921213 [TBL] [Abstract][Full Text] [Related]
38. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease. Khurana M; Silverstein DM Pediatr Nephrol; 2015 Dec; 30(12):2073-84. PubMed ID: 25801207 [TBL] [Abstract][Full Text] [Related]
40. The effect of metabolic acidosis on serum apolipoprotein A I and apolipoprotein B levels in children with chronic renal failure. Bircan Z; Kaplan A; Soran M; Söker M; Kervancioğlu M; Sahin A; Kilinc M Int Urol Nephrol; 1997; 29(5):603-7. PubMed ID: 9413770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]